Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Synthesis and biological evaluation of 17-(/sup 131/I)iodo-9-telluraheptadecanoic acid, a potential imaging agent

Journal Article · · J. Med. Chem.; (United States)
DOI:https://doi.org/10.1021/jm00348a001· OSTI ID:6710647

A method has been developed for the preparation of terminal halogenated tellurium fatty acids (X-R-Te-R'-COOH). The synthesis and physical properties of 17-bromo- and 17-iodo-9-telluraheptadecanoic acid (17-iodo-9-THDA) are described. The radiohalogenated agents are of interest as a result of their expected pronounced and prolonged heart uptake and potential use for evaluation of regional myocardial fatty acid metabolism. Evaluation in rats indicates that the myocardial uptake of 17-(/sup 131/I)iodo-9-telluraheptadecanoic acid (17-(/sup 131/I)iodo-9-THDA) is accompanied by significant in vivo deiodination. A comparison of the heart uptake and deiodination of 17-(/sup 131/I)iodo-9-THDA and 16-(/sup 131/I)iodopalmitic acid has demonstrated a close similarity in blood levels of radioactivity and thyroid uptake of radioiodide after administration of these agents to rats. These data suggest that the mechanism of deiodination of terminal radioiodinated alkanoic acids primarily results from direct cleavage of the carbon-iodine bond and not from loss of radioiodine from the final catabolite.

Research Organization:
Nuclear Medicine Technology Group, Health and Safety Research Division, Oak Ridge National Laboratory, Tennessee
OSTI ID:
6710647
Journal Information:
J. Med. Chem.; (United States), Journal Name: J. Med. Chem.; (United States) Vol. 25:6; ISSN JMCMA
Country of Publication:
United States
Language:
English